Market Closed -
Other stock markets
|
After market 03:34:17 pm | |||
13.26 EUR | -1.41% | 13.2 | -0.45% |
Apr. 18 | Evotec, Variant Bio Team Up to Develop Treatment for Fibrosis | MT |
Apr. 18 | Evotec, Variant Bio Launch Partnership to Develop Treatments for Fibrosis | MT |
Sales 2023 * | 780M 832M | Sales 2024 * | 919M 981M | Capitalization | 2.38B 2.55B |
---|---|---|---|---|---|
Net income 2023 * | -54M -57.63M | Net income 2024 * | 31M 33.09M | EV / Sales 2023 * | 3 x |
Net cash position 2023 * | 46.3M 49.42M | Net cash position 2024 * | 37M 39.49M | EV / Sales 2024 * | 2.56 x |
P/E ratio 2023 * |
-44.2
x | P/E ratio 2024 * |
74
x | Employees | 5,086 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 90.64% |
Latest transcript on Evotec SE
1 day | -2.34% | ||
1 week | -5.01% | ||
Current month | -9.61% | ||
1 month | -3.36% | ||
3 months | -7.72% | ||
6 months | -24.70% | ||
Current year | -38.53% |
Managers | Title | Age | Since |
---|---|---|---|
Mario Polywka
CEO | Chief Executive Officer | 61 | 19-06-18 |
Laetitia Rouxel
DFI | Director of Finance/CFO | 51 | 23-02-06 |
Craig Johnstone
COO | Chief Operating Officer | 54 | 12-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mario Polywka
CEO | Chief Executive Officer | 61 | 19-06-18 |
Roland Sackers
BRD | Director/Board Member | 56 | 19-06-18 |
Chairman | 63 | 14-06-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.68% | 17 M€ | -.--% | - | |
2.59% | 202 M€ | -.--% | ||
0.21% | 79 M€ | -.--% | ||
0.15% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 13.26 | -1.41% | 673 258 |
24-04-18 | 13.45 | +1.82% | 694,213 |
24-04-17 | 13.21 | -0.15% | 617,970 |
24-04-16 | 13.23 | -3.99% | 570,194 |
24-04-15 | 13.78 | +0.07% | 337,584 |
Delayed Quote Xetra, April 19, 2024 at 09:32 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.53% | 2.54B | |
-1.19% | 41.35B | |
+42.10% | 40.38B | |
+4.32% | 39.05B | |
-12.11% | 26.67B | |
+4.24% | 24.07B | |
-24.00% | 18.36B | |
-3.92% | 11.68B | |
+22.50% | 11.6B | |
+7.67% | 11.15B |
- Stock Market
- Equities
- EVT Stock